Geneos Wealth Management’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Geneos Wealth Management’s Portfolio VXX Stock Details VXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-63	Closed	-$14.1K	–	2112
2022 Q4	$14.1K	Sell	63 -11	-15%	-$3.01K	﹤0.01%	1438
2022 Q3	$25K	Hold	74	–	–	﹤0.01%	1257
2022 Q2	$26K	Buy	74 +62	+517%	+$24.5K	﹤0.01%	1578
2022 Q1	$4K	Buy	+12	New	+$4.42K	﹤0.01%	2434
2021 Q1	–	Sell	-209	Closed	-$156K	–	3152
2020 Q4	$156K	Buy	209 +62	+42%	+$80.5K	0.01%	932
2020 Q3	$240K	Buy	147 +64	+77%	+$114K	0.01%	627
2020 Q2	$198K	Buy	+83	New	+$200K	0.01%	672
2020 Q1	–	Sell	-40	Closed	-$38K	–	2616
2019 Q4	$38K	Buy	40 +12	+43%	+$14.5K	﹤0.01%	1402
2019 Q3	$44K	Buy	28 +8	+40%	+$12.7K	﹤0.01%	1255
2019 Q2	$33K	Buy	+20	New	+$35.5K	﹤0.01%	1403

Other funds holding VXX

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

ACM

Arlington Capital Management Arlington Heights, Illinois $177M AUM 44.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geneos Wealth Management's VXX Position: Q1 2023 in Review

Geneos Wealth Management sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q1 2023, closing a stake of 63 shares — an estimated $14.1K sold.

Geneos Wealth Management first reported a position in VXX in Q2 2019 and held it in 10 quarters. The position peaked at $240K in Q3 2020. 58 funds tracked by Wall St. Rank hold VXX as of Q1 2023.

Geneos Wealth Management reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q1 2023 after selling out during the quarter.
Geneos Wealth Management sold 63 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q1 2023, an estimated $14.1K.
Geneos Wealth Management first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2019 and held it in 10 quarters.
Geneos Wealth Management's iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $240K in Q3 2020.
58 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q1 2023.

Based on Geneos Wealth Management's 13F filing for Q1 2023, filed 25 Apr 2023.